Health Minister Michael McGimpsey has hit back overallegations that he “wasted” taxpayers’ money purchasing hundreds of thousands of swine flu vaccines — 60% of which have not been administered. Related Stories Drug addicts ‘need a drop-in centre’
Influenza Headlines and Flu Vaccination Information
Archive for February 10th, 2010
Nine months after the first case of swine flu was diagnosed in Northern Ireland, health chiefs in the province have effectively heralded the end of the pandemic. Related Stories Inquiry demanded into terror suspect’s torture ‘Failures’ at nursery over child protection Paisley and Adams add punch to Haiti appeal Liver failure lad Gareth becomes a pet shop boy Man quizzed over woman's death
The family of a 14-year-old girl who died after contracting swine flu are due to hear the outcome of an investigation into the delay in informing them that she had the virus. - Video available
Sanofi-Aventis SA reported fourth quarter profit that beat analysts' estimates after swine flu vaccine sales helped offset revenue lost to generic rivals.
Starting Monday, the Kanawha-Charleston Health Department will expand its swine flu vaccination clinics to every weekday, according to a press release from the department. The clinics will be held from 8:30 a.m. to 3:30 p.m., Monday through Friday. ...
ATLANTA (AP) — Is the U.S. swine flu (H1N1) epidemic over? Federal health officials won't go so far as to say that, but on Friday they reported for the fourth week in a row that no states had widespread flu activity.
The National Pandemic Flu Service in England is to close because of the sharp decline in cases of the H1N1 swine flu virus.
Sigma-Aldrich says swine flu adjuvant sales boosted 4Q profit 10 percent, topping estimates Sigma-Aldrich - Health - Business - Conditions and Diseases - Viral
Biochemicals company Sigma-Aldrich Corp. said Wednesday its profit grew 10 percent in the fourth quarter, aided by sales of adjuvants that boost the effectiveness of swine flu vaccines. Sigma-Aldrich earned $92.6 million, or 75 cents per share, up from $84.3... Vaccine - Adjuvant - Sigma-Aldrich - Business - Health
Biochemicals company Sigma-Aldrich Corp. said Wednesday its profit grew 10 percent in the fourth quarter, aided by sales of adjuvants that boost the effectiveness of swine flu vaccines.